NeuroOne Medical Technologies Corporation (NMTC)
(Delayed Data from NSDQ)
$0.93 USD
+0.03 (3.33%)
Updated Oct 3, 2025 04:00 PM ET
After-Market: $0.93 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value A Growth C Momentum C VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
NMTC 0.93 +0.03(3.33%)
Will NMTC be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for NMTC based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for NMTC
NMTC Stock Gains as FDA Clears OneRF System for Facial Pain Treatment
NMTC: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for NMTC
Is NMTC showing upside potential? Stochastic Buy Signal shows up after gaining 3.33%
NMTC forms 180 Bullish Setup on October 2
20 Day Moving Average Support appears for NMTC after 0.07% move
Is NMTC positioned for a breakout? 20 Day Moving Average Support shows up after sliding 1.27%
NMTC's price falls by 2.07% on September 29, though its technical setup remains stable.